Hematological Abnormalities of Adult HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: A Cross-Sectional Study

References

• Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Hematol. 2009;9(1):1–6. doi:10.1186/1471-2326-9-5
   Google Scholar
• Kirchhoff F, Silvestri G. Is Nef the elusive cause of HIV-associated hematopoietic dysfunction? J Clin Invest. 2008;118(5):1622–1625. doi:10.1172/JCI35487
   Web of Science ®Google Scholar
• Dhurve SA, Dhurve AS. Bone marrow abnormalities in HIV disease. Mediterr J Hematol Infect Dis. 2013;5(1):e2013033. doi:10.4084/mjhid.2013.033
   PubMedGoogle Scholar
• Muluneh A, Fessahaye A. Hematologic abnormalities among children on HAART in Jimma University specialized hospital, Southwestern Ethiopia. Ethiop J Health Sci. 2009;19(2):83–89.
   Google Scholar
• Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev. 2002;4(1):13–20.
   PubMedGoogle Scholar
• Omoregie R, Omokaro E, Palmer O, et al. Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria. Tanzan J Health Res. 2009;11(1). doi:10.4314/thrb.v11i1.43242
   PubMedGoogle Scholar
• Odunukwe N, Idigbe O, Kanki P, et al. Hematological and biochemical response to treatment of HIV–1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos, Nigeria. Turk J Haematol. 2005;22(3):125–131.
   Google Scholar
• Akinbami A, Oshinaike O, Adeyemo T, et al. Hematologic abnormalities in treatment-naive HIV patients. Infect Dis Res Treat. 2010;3:IDRT- S6033.
   Google Scholar
• Melku M, Enawgaw B, Ayana S, et al. Magnitude of anemia and undernutrition among HIV-infected children who took HAART: a retrospective follow-up study. Am J Blood Res. 2020;10(5):198.
   Web of Science ®Google Scholar
• Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol. 2014;14(1):1–7.
   Google Scholar
• Kouri YH, Borkowsky W, Nardi M, Karpatkin S, Basch RS Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. 1993.
   Google Scholar
• Durandt C, Potgieter J, Khoosal R, et al. HIV and hematopoiesis. S Afr Med J. 2019;109(8, Supplement 1):S41–S6. doi:10.7196/SAMJ.2019.v109i8b.13829
   Web of Science ®Google Scholar
• Evans RH, Scadden DT. Haematological aspects of HIV infection. Best Pract Res Clin Haematol. 2000;13(2):215–230. doi:10.1053/beha.1999.0069
   Web of Science ®Google Scholar
• Jost J, Tauber MG, Luthy R, Siegenthal W. HIV-associated thrombocytopenia. Schweiz Med Wochenschr. 1988;118:206–212.
   PubMedGoogle Scholar
• Vishnu P, Aboulafia DM. Haematological manifestations of human immune deficiency virus infection. Br J Haematol. 2015;171(5):695–709. doi:10.1111/bjh.13783
   Web of Science ®Google Scholar
• Shi X, Sims MD, Hanna MM, et al. Neutropenia during HIV infection: adverse consequences and remedies. Int Rev Immunol. 2014;33(6):511–536. doi:10.3109/08830185.2014.893301
   PubMed Web of Science ®Google Scholar
• Leroi C, Balestre E, Messou E, et al. Incidence of severe neutropenia in HIV-infected people starting antiretroviral therapy in West Africa. PLoS One. 2017;12(1):e0170753. doi:10.1371/journal.pone.0170753
   Web of Science ®Google Scholar
• Geletaw T, Tadesse MZ, Demisse AG. Hematologic abnormalities and associated factors among HIV infected children pre-and post-antiretroviral treatment, North West Ethiopia. J Blood Med. 2017;8:99. doi:10.2147/JBM.S137067
   Web of Science ®Google Scholar
• Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(1):29–33. doi:10.1097/00042560-199809010-00004
   Google Scholar
• Behler C, Shade S, Gregory K, Abrams D, Volberding P. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retrovir. 2005;21(3):200–206. doi:10.1089/aid.2005.21.200
   Web of Science ®Google Scholar
• Denue BA, Kida IM, Hammagabdo A, Dayar A, Sahabi MA. Prevalence of anemia and immunological markers in HIV-infected patients on highly active antiretroviral therapy in Northeastern Nigeria. Infect Dis Res Treat. 2013;6:IDRT–S10477.
   Google Scholar
• Harris RJ, Sterne JA, Abgrall S, et al. Prognostic importance of anemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries. Antivir Ther. 2008;13(8):959.
   Web of Science ®Google Scholar
• Gedefaw L, Yemane T, Sahlemariam Z, Yilma D. Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS One. 2013;8(8):e72202. doi:10.1371/journal.pone.0072202
   PubMed Web of Science ®Google Scholar
• Servais J, Nkoghe D, Schmit JC, et al. HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(3):221–225. doi:10.1097/00042560-200111010-00003
   PubMed Web of Science ®Google Scholar
• Woldeamanuel GG, Wondimu DH. Prevalence of anemia before and after initiation of antiretroviral therapy among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: a cross sectional study. BMC Hematol. 2018;18(1):1–7. doi:10.1186/s12878-018-0097-0
   Google Scholar
• Tsegaye A. Prevalence of anemia before and after initiation of antiretroviral therapy on HIV infected patients at Ras Desta Damtew memorial Hospital, Addis Ababa, Ethiopia. J Med Health Sci. 2018;7:24–31.
   Google Scholar
• Owiredu WK, Quaye L, Amidu N, Addai-Mensah O. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011;11(1):2–15.
   PubMed Web of Science ®Google Scholar
• Rezaei E, Ebrahim-Saraie HS, Heidari H, et al. Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients. Med J Islam Repub Iran. 2016;30:350.
   PubMedGoogle Scholar
• Taremwa IM, Muyindike WR, Muwanguzi E, Boum Y. Prevalence of HIV-related thrombocytopenia among clients at Mbarara Regional Referral Hospital, Mbarara, southwestern Uganda. J Blood Med. 2015;6:109. doi:10.2147/JBM.S80857
   PubMedGoogle Scholar
• Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood. 2005;106(2):572–576. doi:10.1182/blood-2005-01-0243
   Web of Science ®Google Scholar